By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cleveland Biolabs Inc. 

10265 Carnegie Avenue

Cleveland  Ohio  44106  U.S.A.
Phone: 216-445-0814 Fax: 216-636-3429


SEARCH JOBS



Segment
Start Up





Company News
Cleveland Biolabs Inc. (CBLI) Attains Orphan Drug Status From The European Medicines Agency For Entolimod As A Radiation Countermeasure 1/21/2016 11:12:41 AM
Cleveland Biolabs Inc. (CBLI) And Rusnano Make Additional Investments In Panacela 12/22/2015 1:03:36 PM
Entolimod Shown To Suppress Liver Metastases In Model Of Ocular Melanoma In Collaborative Study By Cleveland Biolabs Inc. (CBLI), Emory University, And Roswell Park Cancer Institute 12/15/2015 12:03:25 PM
Cleveland Biolabs Inc. (CBLI) Announces Expanded U.S. Patent Protection For Entolimod 12/1/2015 11:46:13 AM
Cleveland Biolabs Inc. (CBLI) Reports Third Quarter 2015 Financial Results And Development Progress 11/9/2015 2:38:12 PM
Cleveland Biolabs Inc. (CBLI) To Report Third Quarter 2015 Financial Results On November 5 10/27/2015 1:00:28 PM
Department Of Defense Grants Cleveland Biolabs Inc. (CBLI) Second Award For Advanced Development Of Entolimod As A Medical Radiation Countermeasure 9/24/2015 12:22:20 PM
Cleveland Biolabs Inc. (CBLI) Announces Publication Of Studies Demonstrating Efficacy Of Entolimod As A Radiation Countermeasure Up To 48 Hours After Exposure Of Nonhuman Primates To Lethal Radiation 9/18/2015 11:30:50 AM
Cleveland Biolabs Inc. (CBLI) To Present At Rodman & Renshaw 17th Annual Global Investment Conference 9/3/2015 11:43:34 AM
Department Of Defense Awards Cleveland Biolabs Inc. (CBLI) A $9.2 Million Contract For Advanced Development Of Entolimod As A Medical Radiation Countermeasure 9/2/2015 11:30:43 AM
12345678910...
//-->